Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88,059,438
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
56,594,046
-
Shares change
-
+11,034,490
-
Total reported value, excl. options
-
$1,329,917,026
-
Value change
-
+$272,378,345
-
Put/Call ratio
-
3.87%
-
Number of buys
-
99
-
Number of sells
-
-47
-
Price
-
$23.5
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2023
163 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q2 2023.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,594,046 shares
of 88,059,438 outstanding shares and own 64.27% of the company stock.
Largest 10 shareholders include BVF INC/IL (5,683,489 shares), BlackRock Inc. (4,355,696 shares), FEDERATED HERMES, INC. (3,389,698 shares), Avidity Partners Management LP (2,985,700 shares), VANGUARD GROUP INC (2,829,653 shares), Canaan Partners X LLC (2,660,713 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,575,110 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,502,673 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,268,628 shares), and Boxer Capital, LLC (2,202,812 shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.